Literature DB >> 6478770

Kinetic analysis of collagen fibrillogenesis: II. Corneal and scleral type I collagen.

D E Birk, F H Silver.   

Abstract

Fibril formation of neutral salt soluble and pepsin-treated type I collagen from rabbit corneal stroma or sclera was compared using a turbidimetric analysis which permits the determination of apparent rate constants and activation energies for the lag and growth phase of collagen fibrillogenesis. Information regarding the lateral growth of fibrils was obtained from the final turbidity values. Neutral salt soluble corneal collagen had smaller rate constants for both the lag and growth phases of fibrillogenesis than scleral collagen. Pepsin treatment decreased the rate constants for both collagens proportionately. The activation energies were higher for type I collagen from cornea than sclera. Pepsin treatment increased the activation energy for both phases of corneal fibril formation but only the growth phase of scleral collagen fibrillogenesis was affected. The extent of lateral fibril growth was compared using the intrinsic turbidity values which are related to the mass per unit fibril length. Neutral salt soluble scleral type I collagen had a significantly higher intrinsic turbidity than did neutral salt soluble corneal collagen indicating that scleral collagen formed thicker fibrils; however, this difference was not retained after pepsin treatment, demonstrating that a helical-telopeptide interaction occurs in corneal type I collagen which influences fibril diameter. The observed differences in the rate constants, activation energies and intrinsic turbidity values indicates that there are molecular differences which are responsible for fibrillar differences of corneal and scleral type I collagens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478770     DOI: 10.1016/s0174-173x(84)80034-5

Source DB:  PubMed          Journal:  Coll Relat Res        ISSN: 0174-173X


  6 in total

1.  Immunohistochemical studies of glycosaminoglycans in nanophthalmic sclera.

Authors:  M Kawamura; S Tajima; N Azuma; H Katsura; K Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

2.  Biochemical studies of glycosaminoglycans in nanophthalmic sclera.

Authors:  M Kawamura; S Tajima; N Azuma; H Katsura; K Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-02       Impact factor: 3.117

3.  Abnormal sclerocytes in nanophthalmos.

Authors:  T Shiono; A Shoji; T Mutoh; M Tamai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 4.  Prelude to corneal tissue engineering - gaining control of collagen organization.

Authors:  Jeffrey W Ruberti; James D Zieske
Journal:  Prog Retin Eye Res       Date:  2008-08-19       Impact factor: 21.198

5.  Model Systems for Evidencing the Mediator Role of Riboflavin in the UVA Cross-Linking Treatment of Keratoconus.

Authors:  Mihaela Monica Constantin; Cătălina Gabriela Corbu; Sorin Mocanu; Elena Irina Popescu; Marin Micutz; Teodora Staicu; Raluca Şomoghi; Bogdan Trică; Vlad Tudor Popa; Aurica Precupas; Iulia Matei; Gabriela Ionita
Journal:  Molecules       Date:  2021-12-29       Impact factor: 4.411

Review 6.  Bioengineering Approaches for Corneal Regenerative Medicine.

Authors:  S Sharareh Mahdavi; Mohammad J Abdekhodaie; Shohreh Mashayekhan; Alireza Baradaran-Rafii; Ali R Djalilian
Journal:  Tissue Eng Regen Med       Date:  2020-07-21       Impact factor: 4.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.